Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer

Pharmacogenetics

Volumn 10, Issue 1, 2000, Pages 25-33

  Watanabe, Junko ^a   Shimada, Tsutomu ^b   Gillam, Elizabeth M J ^c   Ikuta, Togo ^a   Suemasu, Kimito ^a   Higashi, Yasuhiro ^a   Gotoh, Osamu ^a   Kawajiri, Kaname ^a  

^a SAITAMA CANCER CENTER   (Japan)

^b OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Breast cancer; CYP1B1; Estradiol 4 hydroxylase; Genetic polymorphism; Lung cancer

Indexed keywords

ALANINE; BENZO[A]PYRENE; CARCINOGEN; COMPLEMENTARY DNA; CYTOCHROME P450 1B1; CYTOCHROME P450 ISOENZYME; ESTRADIOL; LEUCINE; UNCLASSIFIED DRUG; VALINE;

ALLELE; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER SUSCEPTIBILITY; CODON; CONTROLLED STUDY; ENZYME SPECIFICITY; ESTROGEN METABOLISM; GENETIC POLYMORPHISM; GENETIC RECOMBINATION; HUMAN; JAPAN; LUNG CANCER; MAJOR CLINICAL STUDY; METABOLIC ACTIVATION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; STEROID HYDROXYLATION;

ADENOCARCINOMA; ARYL HYDROCARBON HYDROXYLASES; BREAST NEOPLASMS; CARCINOMA; CARCINOMA, LARGE CELL; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; CATALYSIS; CYTOCHROME P-450 ENZYME SYSTEM; ESTRADIOL; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INCIDENCE; JAPAN; LUNG NEOPLASMS; MALE; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; REFERENCE VALUES; RISK ASSESSMENT; STEROID HYDROXYLASES; VARIATION (GENETICS);

EID: 0034050485     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-200002000-00004     Document Type: Article

References (31)

1. Bailey LR, Roodi N, Dupont WD, Parl FF. Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer. Cancer Res 1998; 58:5038-5041.
2. Bhattacharyya KK, Brake PB, Eltom SE, Otto SA, Jefcoate CR. Identification of a rat adrenal cytochrome P450 active in polycyclic hydrocarbon metabolism as rat CYP1B1: demonstration of a unique tissue-specific pattern of hormonal and aryl hydrocarbon receptor-linked regulation. J Biol Chem 1995; 270:11595-11602.
3. Christon M, Savas Ü, Spink DC, Gierthy JF. Jefcoate CR. Co-expression of human CYP1A1 and a human analog of cytochrome P450-EF in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin in the human mammary carcinoma-derived MCF-7 cells. Carcinogenesis 1994: 15:725-732.
4. Gotoh O. Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences. J Biol Chem 1992; 267:83-90.
5. Gotoh O, Tagashira Y, Iizuka T, Fujii-Kuriyama Y. Structural characteristics of cytochrome P450; possible location of the heme-binding cysteine in determined amino acid sequence. J Biochem 1983; 93:807-817.
6. Guengerich FP, Shimada T. Oxidation of toxic and carcinogenic chemicals by human cytochrome P450 enzymes. Chem Res Toxicol 1991; 4:391-407.
7. Hayashi S-I, Watanabe J, Nakachi K, Kawajiri K. Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme-binding region of the human cytochrome P450 IA1 gene. J Biochem 1991; 110:407-411.
8. Hayes CL, Spink DC, Spink BC, Cao JO, Walker NJ, Sutter TR. 17β-Estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Pror Natl Acad Sci USA 1996; 93:9776-9781.
9. Kawajiri K, Nakachi K, Imai K, Yoshii A. Shinoda N, Watanabe J. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the P450IA1 gene. FEBS Lett 1990; 263:131-133.
10. Kawajiri K, Nakachi K, Imai K, Watanabe J, Hayashi S-I. The CYP1A1 gene and cancer susceptibility. Crit Rev Oncol Hematol 1993; 14:77-87.
11. Kawajiri K, Watanabe J, Eguchi H, Nakachi K, Kiyohara C, Hayashi S-I. Polymorphisms of human Ah receptor gene are not involved in lung cancer. Pharmacogenetics 1995; 5:151-158.
12. Li JJ. Li SA. Estrogen carcinogenesis in Syrian hamster tissue: role of metabolism. Fed Proc 1987; 46:1858-1863.
13. Liehr JG, Fang WF, Sirbasku DA, Ari-Ulubelen A. Carcinogenicity of catechol estrogens in the Syrian hamster. J Steroid Biochem 1986; 24:353-356.
14. Liehr JG, Ricci MJ, Jefcoate CR, Hanngigan EV, Hokanson JA, Zhu BT. 4-Hydroxylation of estradiol by human uterine myometrium and myoma microsomes: implications for the mechanism of uterine tumorigenesis. Proc Natl Acad Sci USA 1995; 92:9220-9224.
15. Liehr JG, Ricci MJ. 4-Hydroxylation of estrogens as marker of human mammary tumors. Prof Natl Acad Sci USA 1996; 93:3294-3296.
16. Nakachi K, Imai K, Hayashi S-I, Watanabe J, Kawajiri K. Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res 1991; 51:5177-5180.
17. Nebert DW. Role of genetics and drug metabolism in human cancer risk. Mut Res 1991; 247:267-281.
18. Omura T, Sato R. The carbon monoxide-binding pigment of liver microsomes. J Biol Chem 1964; 239:2370-2378.
19. Parikh A, Gillam EMJ. Guengerich FP. Drug metabolism by Escherichia coli expressing human cytochromes P450. Nature Biotechnol 1997; 15:784-788.
20. Savas U, Bhattacharyya KK, Christou M, Alexander DL, Jefcoate CR. Mouse cytochrome P450EF, representative of a new 1B subfamily of cytochrome P450s. Cloning, sequence determination, and tissue expression. J Biol Chem 1994; 269:14905-14911.
21. Shen Z, Liu J, Wells RL, Elkind MM. cDNA cloning, sequence analysis, and induction by aryl hydrocarbons of a murine cytochrome P-450 gene, Cyp1b1. DNA Cell Biol 1994; 13:763-769.
22. Shimada T, Yun C-H, Yamazaki H, Gautier J-C, Beaune PH, Guengerich FP. Characterization of human lung microsomal cytochrome P450 1A1 and its role in oxidation of chemical carcinogens. Mol Pharmacol 1992; 41:856-864.
23. Shimada T, Hayes CL, Yamazaki H, Amin S, Hecht SS, Guengerich FP, Sutter TR. Activation of chemically diverse procarcinogen by human cytochrome P-450 1B1. Cancer Res 1996; 56:2979-2984.
24. Shimada T, Wunsch RM, Hanna IH, Sutter TR, Guengerich FP, Gillam EMJ. Recombinant human cytochrome P450 1B1 expression in Escherichia coli. Arch Biochem Biophys 1998; 357:111-120.
25. Spink DC, Eugster H-P, Lincoln II DW, Schuetz EG, Johnson JA, Kaminsky LS, Gierthy JF. 17β-Estradiol hydroxylation catalyzed by human cytochrome P450 1A1: a comparison of the activities induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in MCF-7 cells with those from heterologous expression of the cDNA. Arch Biochem Biophys 1992; 293:342-348.
26. Spink DC, Hayes CL, Young NR, Christou M, Sutter TR, Jefcoate CR, Gierthy JF. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxine on estrogen metabolism in MCF-7 breast cancer cells: evidence for induction of a novel 17β-estradiol 4-hydroxylase. J Steroid Biochem Molec Biol 1994; 51:251-258.
27. Stoilov I, Akarsu AN, Alozie I, Child A, Barsoum-Homsy M. Turacli ME, et al. Sequence analysis and homology modeling suggest that primary congenital glaucoma on 2p21 results from mutations disrupting either the hinge region or the conserved core structures of cytochrome P4501B1. Am J Hum Genet 1998; 62:573-584.
28. Sutter TR, Tang YM, Hayes C, Wo Y-YP, Jabs EW, Li X, et al. Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J Biol Chem 1994; 269:13092-13099.
29. Tang YM, Wo Y-Y, Stewart J, Hawkins AL, Griffin CA, Sutter TR, Greenlee WF. Isolation and characterization of the human cytochrome P450 CYP1B1 gene. J Biol Chem 1996; 271:28324-28330.
30. Walker N, Gastel JA, Costa LT, Clark GC, Lucier GW, Sutter TR. Rat CYP1B1: an adrenal cytochrome P450 that exhibits sex-dependent expression in livers and kidneys of TCDD-treated animals. Carcinogenesis 1995; 16:1319-1327.
31. WHO. World Health Statistics Annual, Geneva: Switzerland, WHO; 1995.